Coloplast A/S Class B(CLPBF)

Research Snapshot

Coloplast A/S Class B (CLPBF) is a Healthcare stock with a market cap of $91.16B and listed on OTC. The stock last traded around $57.41 and down 36.6% across the available one-year price window (Jun 30, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of +2.9%, EPS growth of -28.3%, a dividend yield of 5.7%. What stands out right now is revenue +2.9%, EPS -28.3%, free cash flow +275.3% with operating margin 27.0% and ROIC 10.9%. The dividend matters to the case here, with a current yield around 5.7%. Valuation is more restrained than many high-expectation growth names at P/E 22.8 and price/sales 3.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CLPBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.